Anti-HLA Class 1 ABC antibody [EMR8-5] (ab70328)

Publishing research using ab70328? Please let us know so that we can cite the reference in this datasheet.

ab70328 has been referenced in 43 publications.

  • Kanangat S  et al. Circulating histocompatibility antigen (HLA) gene products may help differentiate benign from malignant indeterminate pulmonary lesions. Hum Immunol 79:558-563 (2018). WB . PubMed: 29656111
  • Uong TNT  et al. Real-Time Tracking of Ex Vivo-Expanded Natural Killer Cells Toward Human Triple-Negative Breast Cancers. Front Immunol 9:825 (2018). PubMed: 29770131
  • Mordoh J  et al. Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study. Front Immunol 8:625 (2017). IHC-P ; Human . PubMed: 28620382
  • Pavesi A  et al. A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors. JCI Insight 2:N/A (2017). IHC-P ; Human . PubMed: 28614795
  • Lee DJ  et al. Bio-implant as a novel restoration for tooth loss. Sci Rep 7:7414 (2017). PubMed: 28784994
  • Bolognesi MM  et al. Multiplex Staining by Sequential Immunostaining and Antibody Removal on Routine Tissue Sections. J Histochem Cytochem 65:431-444 (2017). PubMed: 28692376
  • Ono T  et al. Association between PD-L1 expression combined with tumor-infiltrating lymphocytes and the prognosis of patients with advanced hypopharyngeal squamous cell carcinoma. Oncotarget 8:92699-92714 (2017). PubMed: 29190949
  • Haworth KB  et al. Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy. Oncotarget 8:82037-82048 (2017). PubMed: 29137242
  • Sade-Feldman M  et al. Resistance to checkpoint blockade therapy through inactivation of antigen presentation. Nat Commun 8:1136 (2017). PubMed: 29070816
  • Lechner A  et al. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma. Oncotarget 8:44418-44433 (2017). PubMed: 28574843
  • Park IA  et al. Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling. PLoS One 12:e0182786 (2017). PubMed: 28817603
  • Zhang L  et al. Malignant pericytes expressing GT198 give rise to tumor cells through angiogenesis. Oncotarget 8:51591-51607 (2017). PubMed: 28881671
  • Yamashita Y  et al. HLA-DP84Gly constitutively presents endogenous peptides generated by the class I antigen processing pathway. Nat Commun 8:15244 (2017). WB . PubMed: 28489076
  • Colangelo T  et al. Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer. Cell Death Dis 7:e2120 (2016). WB . PubMed: 26913609
  • Jung IH  et al. Impaired Lymphocytes Development and Xenotransplantation of Gastrointestinal Tumor Cells in Prkdc-Null SCID Zebrafish Model. Neoplasia 18:468-79 (2016). IHC . PubMed: 27566103
  • Fucikova J  et al. Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis. Cancer Res 76:1746-56 (2016). PubMed: 26842877
  • Faltermeier CM  et al. Functional screen identifies kinases driving prostate cancer visceral and bone metastasis. Proc Natl Acad Sci U S A 113:E172-81 (2016). PubMed: 26621741
  • Vishnubalaji R  et al. Angiogenic Potential of Human Neonatal Foreskin Stromal Cells in the Chick Embryo Chorioallantoic Membrane Model. Stem Cells Int 2015:257019 (2015). PubMed: 26221144
  • Lee HJ  et al. Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab. Am J Clin Pathol 144:278-88 (2015). PubMed: 26185313
  • Huang L  et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nat Med 21:1364-71 (2015). PubMed: 26501191
  • Sokol L  et al. Loss of tapasin correlates with diminished CD8(+) T-cell immunity and prognosis in colorectal cancer. J Transl Med 13:279 (2015). PubMed: 26310568
  • Li X  et al. NLRC5 expression in tumors and its role as a negative prognostic indicator in stage III non-small-cell lung cancer patients. Oncol Lett 10:1533-1540 (2015). PubMed: 26622704
  • Nada OH  et al. Prognostic significance of HLA EMR8-5 immunohistochemically analyzed expression in osteosarcoma. Diagn Pathol 9:72 (2014). IHC . PubMed: 24667142
  • Amendola D  et al. Human placenta-derived neurospheres are susceptible to transformation after extensive in vitro expansion. Stem Cell Res Ther 5:55 (2014). PubMed: 24754904
  • Mannino M  et al. Differential sensitivity of Glioma stem cells to Aurora kinase A inhibitors: implications for stem cell mitosis and centrosome dynamics. Stem Cell Res 13:135-43 (2014). ICC/IF ; Human . PubMed: 24879067
  • Pesciotta EN  et al. Dysferlin and other non-red cell proteins accumulate in the red cell membrane of Diamond-Blackfan Anemia patients. PLoS One 9:e85504 (2014). WB ; Human . PubMed: 24454878
  • Duan H  et al. Engineering of epidermis skin grafts using electrospun nanofibrous gelatin/ polycaprolactone membranes. Int J Nanomedicine 8:2077-84 (2013). IHC-Fr ; Human . PubMed: 23766645
  • Zhang A  et al. The spatio-temporal expression of MHC class I molecules during human hippocampal formation development. Brain Res 1529:26-38 (2013). PubMed: 23838325
  • Ogbomo H  et al. Myxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivo. PLoS One 8:e66825 (2013). WB . PubMed: 23762498
  • Zhao Y  et al. Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model. J Thorac Cardiovasc Surg N/A:N/A (2013). PubMed: 24199758
  • da Silva GB  et al. Expression of the Classical and Nonclassical HLA Molecules in Breast Cancer. Int J Breast Cancer 2013:250435 (2013). IHC-FrFl ; Human . PubMed: 24363939
  • Lee EJ  et al. Regeneration of peripheral nerves by transplanted sphere of human mesenchymal stem cells derived from embryonic stem cells. Biomaterials 33:7039-46 (2012). IHC . PubMed: 22795857
  • Baiguera S  et al. Development of bioengineered human larynx. Biomaterials 32:4433-42 (2011). IHC-P ; Human . PubMed: 21474177
  • Lee HW  et al. Prognostic significance of HLA class I expressing in gastric carcinoma defined by monoclonal anti-pan HLA class I antibody, EMR8-5. J Gastrointest Surg 15:1336-43 (2011). IHC-P ; Human . PubMed: 21512844
  • Pollack BP  et al. Epidermal growth factor receptor inhibition augments the expression of MHC class I and II genes. Clin Cancer Res 17:4400-13 (2011). IHC-P ; Human . PubMed: 21586626
  • Nguyen-Van D  et al. Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8 T-cell epitopes. Am J Blood Res 1:146-59 (2011). PubMed: 22432076
  • Feingold B  et al. Tolerance to incompatible ABO blood group antigens is not observed following homograft implantation. Hum Immunol 72:835-40 (2011). PubMed: 21712059
  • Asnaghi MA  et al. A double-chamber rotating bioreactor for the development of tissue-engineered hollow organs: from concept to clinical trial. Biomaterials 30:5260-9 (2009). IHC-P ; Human . PubMed: 19647867
  • Mizukami Y  et al. Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma. Br J Cancer 99:1462-7 (2008). Human . PubMed: 18841157
  • Kikuchi E  et al. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer. Cancer Sci 98:1424-30 (2007). Human . PubMed: 17645781
  • Kitamura H  et al. Down-regulation of HLA class I antigens in prostate cancer tissues and up-regulation by histone deacetylase inhibition. J Urol 178:692-6 (2007). PubMed: 17574613
  • Kitamura H  et al. Down-regulation of HLA class I antigen is an independent prognostic factor for clear cell renal cell carcinoma. J Urol 177:1269-72; discussion 1272 (2007). PubMed: 17382705
  • Tsukahara T  et al. Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5. Cancer Sci 97:1374-80 (2006). Human . PubMed: 16995877


Sign up